Correlation Between Champions Oncology and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Champions Oncology and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Fennec Pharmaceuticals.
Diversification Opportunities for Champions Oncology and Fennec Pharmaceuticals
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Champions and Fennec is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Champions Oncology i.e., Champions Oncology and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Champions Oncology and Fennec Pharmaceuticals
Given the investment horizon of 90 days Champions Oncology is expected to under-perform the Fennec Pharmaceuticals. In addition to that, Champions Oncology is 3.15 times more volatile than Fennec Pharmaceuticals. It trades about -0.22 of its total potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 655.00 in Fennec Pharmaceuticals on November 27, 2024 and sell it today you would earn a total of 10.00 from holding Fennec Pharmaceuticals or generate 1.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Champions Oncology |
| Fennec Pharmaceuticals |
Champions Oncology and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Fennec Pharmaceuticals
The main advantage of trading using opposite Champions Oncology and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |